Vergoeding 2018-2022 voor ATC-subgroep A10BB : Sulfonylureumderivaten
- Raming voor de totale Zvw-populatie
2018 | 2019 | 2020 | 2021 | 2022 | |
---|---|---|---|---|---|
A10BB01 Glibenclamide | 51.294 | 56.425 | 63.453 | 12.857 | 3.476 |
A10BB03 Tolbutamide | 1.251.000 | 1.436.600 | 1.410.600 | 1.253.400 | 1.055.900 |
A10BB09 Gliclazide (Diamicron ®) | 5.425.000 | 6.399.600 | 6.694.300 | 8.658.800 | 9.240.400 |
A10BB12 Glimepiride (Amaryl ®) | 764.600 | 768.870 | 739.740 | 677.010 | 625.510 |
Totaal | 7.491.894 | 8.661.495 | 8.908.093 | 10.602.067 | 10.925.286 |